Managed Healthcare Executive1d
Monoclonal Antibody Bentracimab Shown to Reverse Antiplatelet Effect of Brilinta | ACC 2025
A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...
The American Journal of Managed Care4d
Ticagrelor Antidote Bentracimab Safely Reverses Antiplatelet Effects in Phase 3 REVERSE-IT Trial
Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.
Ticagrelor antidote safely, effectively restores platelet function and treats bleeding
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's ...
Mirage News2d
Monoclonal Antibody Reverses Heart Attack Drug Effects
An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic ...
Medpage Today on MSN1d
Runners' Cardiac Toll Down; IABP Flop in Cardiogenic Shock; Progress on Oral PCSK9i
The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...
EurekAlert!5d
Ticagrelor antidote safely, effectively restores platelet function and treats bleeding
25). “The antidote, bentracimab, rapidly restored normal platelet function in ticagrelor-treated patients,” said Deepak L. Bhatt, MD, MPH, MBA, director of the Mount Sinai Fuster Heart ...
Healio5d
Antidote to ticagrelor reverses bleeding, restores platelet function
Please provide your email address to receive an email when new articles are posted on . Bentracimab restored platelet function in patients on ticagrelor with major bleeding or undergoing urgent ...